<DOC>
	<DOC>NCT00135837</DOC>
	<brief_summary>Age related macular degeneration is the leading cause of blindness for people over 50 in the western world. Blood vessels which start to grow form a lesion in the back of the eye. Verteporfin may stabilize the disease, by closing the blood vessels. This study will assess the efficacy and safety of verteporfin in patients with occult only lesions.</brief_summary>
	<brief_title>Photodynamic Therapy in Occult-Only Lesions (POOL)</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Verteporfin</mesh_term>
	<criteria>50 years or older Must see better or equal to 34 letters (visual acuity) Choroidal neovascularization (CNV) lesion must be occult only Evidence of classic CNV in the lesion Prior treatment of disease in study eye Have a history of moderate to severe hepatic impairment Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>Age related Macula Degeneration,</keyword>
	<keyword>AMD,</keyword>
	<keyword>choroidal neovascularisation (CNV),</keyword>
	<keyword>occult CNV lesion,</keyword>
	<keyword>verteporfin for injection,</keyword>
	<keyword>photodynamic therapy (PDT)</keyword>
</DOC>